Patrick Oeckl

6.8k total citations · 1 hit paper
86 papers, 3.2k citations indexed

About

Patrick Oeckl is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Patrick Oeckl has authored 86 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Neurology, 36 papers in Molecular Biology and 36 papers in Physiology. Recurrent topics in Patrick Oeckl's work include Alzheimer's disease research and treatments (34 papers), Parkinson's Disease Mechanisms and Treatments (25 papers) and Amyotrophic Lateral Sclerosis Research (23 papers). Patrick Oeckl is often cited by papers focused on Alzheimer's disease research and treatments (34 papers), Parkinson's Disease Mechanisms and Treatments (25 papers) and Amyotrophic Lateral Sclerosis Research (23 papers). Patrick Oeckl collaborates with scholars based in Germany, Italy and United Kingdom. Patrick Oeckl's co-authors include Markus Otto, Petra Steinacker, Albert C. Ludolph, Steffen Halbgebauer, André Huss, Christine A. F. Von Arnim, Jochen H. Weishaupt, Jens Kühle, Samir Abu‐Rumeileh and Boris Ferger and has published in prestigious journals such as Nature, PLoS ONE and Neurology.

In The Last Decade

Patrick Oeckl

83 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blood GFAP as an emerging biomarker in brain and spinal cord disorders

2022 427 citations Ahmed Abdelhak, Matteo Foschi et al. Nature Reviews Neurology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Patrick Oeckl	1.3k	1.2k	1.1k	634	551	86	3.2k
Petra Steinacker	1.8k 1.3×	1.9k 1.6×	1.7k 1.6×	851 1.3×	479 0.9×	107	4.4k
Luisa Benussi	1.3k 1.0×	1.7k 1.5×	2.3k 2.2×	953 1.5×	504 0.9×	138	5.0k
Liisa Myllykangas	1.7k 1.3×	1.0k 0.8×	1.3k 1.2×	594 0.9×	527 1.0×	71	3.3k
Sanna‐Kaisa Herukka	891 0.7×	889 0.7×	1.9k 1.8×	636 1.0×	523 0.9×	106	3.5k
Nadia D’Ambrosi	757 0.6×	1.0k 0.8×	437 0.4×	940 1.5×	595 1.1×	56	3.2k
Annachiara Cagnin	1.2k 0.9×	749 0.6×	1.1k 1.0×	1.3k 2.1×	701 1.3×	59	3.5k
Masaaki Waragai	1.2k 0.9×	1.0k 0.9×	1.0k 1.0×	466 0.7×	765 1.4×	85	3.0k
Lorenzo Gaetani	1.2k 0.9×	635 0.5×	705 0.7×	475 0.7×	376 0.7×	70	2.6k
Kuen‐Jer Tsai	936 0.7×	1.1k 0.9×	744 0.7×	459 0.7×	360 0.7×	77	2.9k
María Isabel Behrens	1.1k 0.8×	1.5k 1.2×	967 0.9×	566 0.9×	822 1.5×	90	3.5k

Countries citing papers authored by Patrick Oeckl

Since Specialization

Citations

This map shows the geographic impact of Patrick Oeckl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Oeckl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Oeckl more than expected).

Fields of papers citing papers by Patrick Oeckl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Oeckl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Oeckl. The network helps show where Patrick Oeckl may publish in the future.

Co-authorship network of co-authors of Patrick Oeckl

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Oeckl. A scholar is included among the top collaborators of Patrick Oeckl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Oeckl. Patrick Oeckl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barba, Lorenzo, Giovanni Bellomo, Daniel Alcolea, et al.. (2025). Serum level changes of the synaptic marker beta-synuclein in Alzheimer’s disease continuum and other dementias. Journal of Neurology Neurosurgery & Psychiatry. 96(12). jnnp–2025.

Segura, Inmaculada, Max Hartmann, Karin M. Danzer, et al.. (2025). Comparing loss of individual fragile X proteins suggests strong links to cellular senescence and aging. Cellular and Molecular Life Sciences. 82(1). 358–358.

Muqaku, Besnik, et al.. (2025). Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosis. EMBO Molecular Medicine. 17(8). 1926–1949.

Barba, Lorenzo, Christoph Vollmuth, Steffen Halbgebauer, et al.. (2024). Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation. European Journal of Neurology. 32(1). e16581–e16581. 3 indexed citations

Barba, Lorenzo, Giovanni Bellomo, Patrick Oeckl, et al.. (2024). CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases. Journal of the Neurological Sciences. 462. 123059–123059. 2 indexed citations

Barba, Lorenzo, Samir Abu‐Rumeileh, Steffen Halbgebauer, et al.. (2023). CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease. Neurology. 101(1). e50–e62. 24 indexed citations

Abu‐Rumeileh, Samir, Steffen Halbgebauer, Lorenzo Barba, et al.. (2023). High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease. Annals of Clinical and Translational Neurology. 10(10). 1904–1909. 7 indexed citations

Oeckl, Patrick, Sarah Anderl‐Straub, Christine A. F. Von Arnim, et al.. (2022). Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion. Journal of Neurology Neurosurgery & Psychiatry. 93(6). 659–667. 64 indexed citations

Abdelhak, Ahmed, Matteo Foschi, Samir Abu‐Rumeileh, et al.. (2022). Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nature Reviews Neurology. 18(3). 158–172. 427 indexed citations breakdown →

10.

Massa, Federico, et al.. (2021). Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration. Journal of Neural Transmission. 129(2). 207–230. 60 indexed citations

11.

Witzel, Simon, Felix Frauhammer, Petra Steinacker, et al.. (2021). Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials. Translational Neurodegeneration. 10(1). 31–31. 20 indexed citations

12.

Steinacker, Petra, MHD Rami Al Shweiki, Patrick Oeckl, et al.. (2021). Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder. Journal of Psychiatric Research. 144. 54–58. 48 indexed citations

13.

Devos, David, Caroline Moreau, Maéva Kyheng, et al.. (2020). Author Correction: A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Scientific Reports. 10(1). 3312–3312. 2 indexed citations

14.

Shweiki, MHD Rami Al, Patrick Oeckl, Petra Steinacker, et al.. (2020). S-ketamine induces acute changes in the proteome of the mouse amygdala. Journal of Proteomics. 216. 103679–103679. 7 indexed citations

15.

Shweiki, MHD Rami Al, Patrick Oeckl, Petra Steinacker, et al.. (2020). Proteomic analysis reveals a biosignature of decreased synaptic protein in cerebrospinal fluid of major depressive disorder. Translational Psychiatry. 10(1). 144–144. 32 indexed citations

16.

Steenoven, Inger van, Marleen J.A. Koel‐Simmelink, Leonie J.M. Vergouw, et al.. (2020). Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach. Molecular Neurodegeneration. 15(1). 36–36. 54 indexed citations

17.

Marques, Tainá M., Anouke van Rumund, Patrick Oeckl, et al.. (2019). Serum NFL discriminates Parkinson disease from atypical parkinsonisms. Neurology. 92(13). e1479–e1486. 95 indexed citations

18.

Devos, David, Caroline Moreau, Maéva Kyheng, et al.. (2019). A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Scientific Reports. 9(1). 2918–2918. 114 indexed citations

19.

Steenoven, Inger van, Barbara Noli, Cristina Cocco, et al.. (2019). VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies. International Journal of Molecular Sciences. 20(19). 4674–4674. 25 indexed citations

20.

Rué, Laura, Patrick Oeckl, Mieke Timmers, et al.. (2019). Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis. Acta Neuropathologica Communications. 7(1). 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact